Evidence map›Paper›PMID 21606325›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Islet amyloid polypeptide demonstrates a persistent capacity to disrupt membrane integrity.

Nicholas B Last, Elizabeth Rhoades, Andrew D Miranker

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 136 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. β-Amyloid aggregation and heterogeneous nucleation.Protein science : a publication of the Protein Society · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nicholas B LastDepartment of Molecular Biophysics and Biochemistry, Yale University, 260 Whitney Avenue, New Haven, CT 06520-8114, USA.
Elizabeth Rhoades
Andrew D Miranker
Yale University · USWhitney Museum of American Art · US

Funding

Skill Development for Diverse Scientific Careers: A New Course Predoctoral Program in Cellular and Molecular BiologyT32GM007223 · NIGMS · YALE UNIVERSITY · PI BASERGA, SUSAN J · 1985 to 2019
$31.0M
Small molecule interference of bilayer catalyzed fiber formationR21DK079829 · NIDDK · YALE UNIVERSITY · PI MIRANKER, ANDREW D. · 2008 to 2009
$429k
Conformations and dynamics of amyloid-induced membrane disruptionR21GM084391 · NIGMS · YALE UNIVERSITY · PI MIRANKER, ANDREW D., RHOADES, ELIZABETH · 2008 to 2009
$417k
NIDDK NIH HHS DK079829NIDDK NIH HHS R21 DK079829NIGMS NIH HHS GM084391NIGMS NIH HHS R21 GM084391NIGMS NIH HHS T32 GM007223
6 · The paper itself

Abstract

Amyloid fiber formation is correlated with pathology in many diseases, including Alzheimer's, Parkinson's, and type II diabetes. Although β-sheet-rich fibrillar protein deposits define this class of disorder, increasing evidence points toward small oligomeric species as being responsible for cell dysfunction and death. The molecular mechanism by which this occurs is unknown, but likely involves the interaction of these species with biological membranes, with a subsequent loss of integrity. Here, we investigate islet amyloid polypeptide, which is implicated in the loss of insulin-secreting cells in type II diabetics. We report the discovery of oligomeric species that arise through stochastic nucleation on membranes and result in disruption of the lipid bilayer. These species are stable, result in all-or-none leakage, and represent a definable protein/lipid phase that equilibrates over time. We characterize the reaction pathway of assembly through the use of an experimental design that includes both ensemble and single-particle evaluations. Complexity in the reaction pathway could not be satisfied using a two-state description of membrane-bound monomer and oligomeric species. We therefore put forward a three-state kinetic framework, one of which we conjecture represents a non-amyloid, non-β-sheet intermediate previously shown to be a candidate therapeutic target.

Indexed as

Models, BiologicalModels, ChemicalAlgorithmsAnimalsCell MembraneCell Membrane PermeabilityDextransFluoresceinHumansIslet Amyloid PolypeptideKineticsLipid BilayersLiposomesMembrane LipidsPhosphatidylethanolaminesProtein Binding1,2-dipalmitoyl-3-phosphatidylethanolamineDextransFluoresceinIslet Amyloid PolypeptideLipid BilayersLiposomesMembrane LipidsPhosphatidylethanolamines

Identifiers

PMID21606325
PMCPMC3111278
OpenAlexW2084414517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.